Tumor Therapeutic Agent

Patent No. EP3338779 (titled "Tumor Therapeutic Agent") was filed by Eisai R&D Management on Aug 18, 2016. The application was issued on Jun 30, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STADA ARZNEIMITTELMar 29, 2022HAMM&WITTKOPP PATENTANWÄLTE PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3338779

EISAI R&D MANAGEMENT
Application Number
EP16837150A
Filing Date
Aug 18, 2016
Status
Revoked
Aug 30, 2025
Publication Date
Jun 30, 2021